All Sauce from Weekly Gravy:

Women who enter menopause at a later age have a greater risk of asthma, a new study says. Meanwhile, early menopause is associated with a reduced risk of developing asthma, researchers found. The results run counter to other studies suggesting that early menopause, defined as ages 40 to 44, is more detrimental to a woman’s health, increasing her risk of heart disease, diabetes, osteoporosis and depression, the researchers noted. They also provide additional evidence for a link between female hormones and asthma, the team led by Durmalouk Kesibi, from York University in Toronto, found. Childhood asthma is more prevalent in boys than girls, but adult-onset asthma is more common in women than men. Women also tend to have more severe asthma, and they are less likely to have their asthma go into remission, researchers noted. “This study highlights sex-based differences in asthma, with women at a greater risk for asthma than men in adulthood,” said Dr. Stephanie Faubion, medical director for The Menopause Society. “It also showed that women with later onset of menopause are at greater risk than those with early onset of menopause,” Faubion added in a society news release. “Clinicians should be aware of this link and should monitor women with later age at natural menopause for asthma symptoms.” For this study, researchers reviewed data on more than 14,000 postmenopausal women with…  read on >  read on >

Pancreatic cancer rates are rising in adults younger than 50, but many continue to believe it’s a disease that only affects the elderly, a new survey shows. Folks in that age range also say they wouldn’t be able to identify early signs and symptoms of pancreatic cancer, and that there’s nothing to do to reduce their risk. “Pancreatic cancer rates have been rising by about 1% annually, and we are seeing this disease in people who are in their 40s much more regularly,” said researcher Zobeida Cruz-Monserrate, co-leader of Carcinogenesis and Chemoprevention Program at the Ohio State University Comprehensive Cancer Program. “This is a concerning trend, and one for which research is needed to learn why.” The survey involved 1,004 people polled in early October. A third (33%) of adults under 50 believed that only seniors are at risk of developing the cancer, the poll results showed. And more than half (53%) said they wouldn’t recognize symptoms of pancreatic cancer, the survey found. About 37% said there’s nothing they can do to change their risk of pancreatic cancer — which isn’t true, Cruz-Monserrate said. Dropping some pounds can lower one’s risk, for a start. Obesity increases a person’s lifetime risk of pancreatic cancer by 20%, the researchers noted. At the same time, only 1 in 10 pancreatic cancers are linked to genetics. “You can’t change…  read on >  read on >

For many reasons, bodybuilders and others involved in weight training might have to take a break from the gym. However, new Finnish research finds that even weeks-long interruptions in training won’t hamper muscle-building efforts. “Of course, the break slows progress some, but it is comforting to know that it is possible to reach the pre-break level surprisingly quickly,” said study lead author Eeli Halonen. He’s a doctoral student in sport and health sciences at the University of Jyväskylä. Halonen and his colleagues published their findings recently in the Scandinavian Journal of Medicine and Science in Sports. In the new study, 42 adults (just over half were males) took part in one of two 20-week weight-training regimens. In one group, folks engaged in weight-training sessions (exercises included leg presses and biceps curls) for the whole 20 weeks without interruption. The second group exercised for 10 weeks, then took a 10-week break, then resumed exercise for another 10 weeks. “Results for maximum strength and muscle size development were similar in both groups,” the researchers concluded in a university news release. For the 20 people that took the 10-week break midway, all measures of muscle improvement bounced back quickly, Halonen’s group said. “During the first few weeks after the break, progress was very rapid and after only five weeks of re-training, the pre-break level had already been reached,”…  read on >  read on >

Most kids with attention issues won’t go on to develop serious psychiatric conditions like psychosis or schizophrenia. However, a new study finds poor attention spans in childhood, plus certain genes, could play a role in raising the risk for these conditions. Of course, much more research is needed to pinpoint precursors to psychotic symptoms in a person’s teens or 20s, said a team from the University of California, Los Angeles. Even if children have certain risk factors, that’s still not a guarantee of psychiatric illness in adulthood, they stressed. “If you have this strong liability based on your genetics and early attentional span, we don’t know what the longer-term trajectories are and who are the people who are going to be more resilient to their underlying risk,” explained study lead author Dr. Carrie Bearden. “That’s going to be really important to look at when those [better] data become available,” said Bearden, a professor at the UCLA Health Semel Institute and the UCLA Health Brain Research Institute. Her team published its findings Oct. 28 in the journal Nature Mental Health. The study looked at cognitive, brain and genetic data for more than 10,000 children tracked for an average of six years, from about age 9 into adolescence. Bearden’s team sought to compare rates of attentional issues in childhood, plus certain genetics, against the likelihood of a…  read on >  read on >

Smoking marijuana during pregnancy may quell your morning sickness, but it could also harm your child’s development, a new study warns. Cannabis exposure in the womb is associated in early childhood with poorer thinking skills, researchers reported Oct. 28 in the journal JAMA Pediatrics. These kids also have behavioral problems like impulse control, poor attention and aggressive behavior, researchers found. “Although cannabis is a natural product, there are still many risks to using it during pregnancy,” said lead researcher Sarah Keim, principal investigator in the Center for Biobehavioral Health at Nationwide Children’s Hospital in Ohio. “Some women may turn to cannabis to help deal with some common issues of pregnancy including nausea, sleep problems and stress,” Keim said. “This is not recommended. Consulting with a health care provider to find safer options to help with these issues during pregnancy is important.” For the study, researchers combined multiple assessment tools to track the development of preschool children. Kids exposed to weed during pregnancy had more difficulty controlling their impulses, paying attention and planning, based on observations of their behavior in a play laboratory environment. They also tended to show more aggressive behavior. “Our findings were not surprising — they actually confirm and expand on longstanding evidence from previous research,” Keim said in a hospital news release. “With our more contemporary and diverse sample of women and…  read on >  read on >

Repeated concussions dramatically increase a hockey player’s risk of depression and burnout, a new study warns. Hockey players who’d suffered three or more concussions had twice the risk of depression symptoms than whose who’d never had a concussion, researchers found. They also faced three and a half times the risk of burnout symptoms, results showed. Concussion caused these effects in both male and female players, the researchers noted. “Other studies have shown that women experience more short-term symptoms after a concussion than men, but it was interesting that the link between concussion and heightened prevalence of symptoms of depression, anxiety and burnout was equally strong for both sexes,” said lead researcher Mitchell Andersson, a doctoral student in psychiatry at Lund University in Sweden. “This might indicate that the long-term neuropsychiatric recovery process is more similar in men and women than the short-term process,” Andersson added in a university news release. For the study, researchers surveyed nearly 650 active hockey players in Sweden’s top hockey divisions. They found that more than 1 in 4 men and nearly 1 in 5 women reported having suffered three or more concussions. Both men and women had a higher risk of depression if they’d suffered repeated concussions, researchers found. Athletes with at least three concussions were also 3.5 times more likely to develop burnout as those with none, and twice…  read on >  read on >

The weight-loss drug Ozempic can guard against kidney disease in obese people, a new study shows. Patients taking semaglutide — the active agent in Ozempic and Wegovy — had as much as a 52% reduction in kidney damage, as measured by urine testing, researchers reported Oct. 25 in the journal Nature Medicine. The results will also be presented simultaneously at the American Society of Nephrology’s annual meeting. Semaglutide patients also had a 30% reduction in kidney inflammation, researchers found. “The great thing is that the drug has both direct and indirect effects on the kidneys,” said lead researcher Hiddo Heerspink, a clinical pharmacologist with the University Medical Center Groningen in the Netherlands. “The drug has direct effects on inflammation parameters in the kidney, and lowers fat tissue around the kidneys, lowering the amount of protein in the urine,” Heerspink said. “And indirectly because it reduces participants‘ weight and blood pressure.” For the study, researchers recruited 101 obese people with chronic kidney disease in Canada, Germany, Spain and the Netherlands, starting in 2022. Half received injections of semaglutide for 24 weeks, while the other half received a placebo. Participants taking the drug lost about 10% of their weight, and they also experienced a decrease in high blood pressure similar to that from taking a blood pressure medication, researchers found. The results also show that the drug…  read on >  read on >

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim their waistlines, a new report finds. Prescriptions of this GLP-1 class of diabetes and weight-loss medications more than doubled between 2022 and 2023, a new tally finds. “In contrast, there was a 25.6% decrease in patients undergoing metabolic bariatric surgery” during the same time period, reported a team led by Dr. Thomas Tsai, an assistant professor of surgery at Harvard Medical School in Boston. Since the U.S. Food and Drug Administration approved Wegovy (the first GLP-1 medicine aimed at weight loss) in mid-2021, sales of the drug and related GLP-1 meds such as Ozempic, Mounjaro and Zepbound have soared. Rapid weight loss has been a hallmark of these medications, which work, in part, by making folks feel full earlier. Prior to the advent of GLP-1s, diet and exercise or bariatric surgeries were the main routes to weight loss for obese Americans. However, the “Ozempic era” may have changed all that, Tsai’s team said. “Anecdotally, health systems have closed hospital-based metabolic bariatric surgery programs due to decreased demand,” they noted in the introduction to their study. To get at harder numbers, the researchers tracked data from the medical records of more than 17 million Americans insured via private coverage or Medicare Advantage. All patients were non-diabetic but…  read on >  read on >

Texts deliver rapid-fire messages, but a new study indicates human brains can keep up with the barrage. The brain can detect the basic linguistic structure of a brief sentence in roughly 150 milliseconds — about the speed of a blink of an eye, researchers report. “Our experiments reveal that the brain’s language comprehension system may be able to perceive language similarly to visual scenes, whose essence can be grasped quickly from a single glance,” said lead researcher Liina Pylkkanen, a professor in New York University’s Department of Linguistics and Department of Psychology. In essence, text or images can be taken in and processed much more quickly than anything someone might say to a person, researchers said. “The human brain’s processing capacity for language may be much faster than what we might think,” Pylkkanen said in a university news release. “In the amount of time it takes to hear one syllable, the brain can actually detect the structure of a short sentence.”   The rise of email, followed by texts and social media, has promoted a quick and fragmented consumption of information, researchers said. Short messages are constantly flashing at people through phone notifications and online platforms. “This shift has made it clear that our brains not only have the ability to instinctively process rapid messages, but can also make snap decisions based on them — like…  read on >  read on >

Medication and behavioral therapy are both effective in combatting fatigue caused by multiple sclerosis (MS), either separately or together, a new study finds. MS patients felt significantly less fatigue after they were prescribed modafinil (Provigil), a drug that promotes wakefulness and is used to treat sleepiness, researchers reported recently in The Lancet Neurology journal. Patients also reported less fatigue after they were given cognitive behavioral therapy (CBT), in which they were taught to recognize the factors that make their fatigue symptoms worse or better. Combining the two treatments, drugs and therapy, provided about the same results as either on their own. However, a person’s own sleep habits also played a role in whether one or the other would work better, researchers discovered. “This research offers new evidence to show that both CBT and modafinil are comparably effective for MS fatigue, which could shape treatment approaches to one of the most challenging symptoms experienced by people with multiple sclerosis,” said lead researcher Dr. Tiffany Braley, director of the University of Michigan Health’s Multiple Sclerosis/Neuroimmunology Division. As many as 90% of the nearly 3 million people with MS worldwide experience fatigue, and nearly half describe it as their worst symptom. For this study, researchers randomly assigned nearly 340 patients to either undergo CBT, take modafinil, or use both. More than 60% of participants in each group reported…  read on >  read on >